(Archived Content)
U.S. Treasury Assistant Secretary David G. Nason will discuss Treasury efforts to strengthen the competitiveness of U.S. capital markets (http://www.treasury.gov/about/organizational-structure/offices/Pages/Capital-Markets) before the City of London Corporation in London, England on Tues., Dec. 11.
When U.S. Treasury Secretary Henry M. Paulson, Jr. first took office, he said (https://www.treasury.gov/press-center/press-releases/Pages/hp174) promoting the competitiveness of U.S. capital markets is a vital issue to strengthening the U.S. economy. He hosted a major conference (https://www.treasury.gov/press-center/press-releases/Pages/hp304) in March with international leaders on this issue.
As part of his plan (https://www.treasury.gov/press-center/press-releases/Pages/hp476) for strengthening American capital markets he called for an examination of the structure of the U.S. financial regulatory system. One area of focus has been the difference between the U.S. financial regulatory structure and regulators around the world, including the benefits of the U.K. financial regulatory structure. Additionally, Treasury has been examining the benefits and consequences of the overlapping federal and state-based oversight on issues such as mortgage origination and insurance. The Department will release its recommendations for improvement early next year. For more information on the Secretary’s capital markets competitiveness initiative, please visithttp://www.treasury.gov/about/organizational-structure/offices/Pages/Capital-Markets
The following event is open to media:
Who U.S. Treasury Assistant SecretaryDavid G. Nason U.S. Treasury Assistant SecretaryDavid G. Nason** What Remarks on American CapitalMarkets Competitiveness** Remarks on American CapitalMarkets Competitiveness** When Tuesday, December 11, 200711:30 a.m. (Local Time)** Tuesday, December 11, 200711:30 a.m. (Local Time)** Where City of London Corporation Mansion HouseLondon, England EC4N 8BH** City of London Corporation Mansion HouseLondon, England EC4N 8BH**-30-**